Chlamydia trachomatis is the most reported STI in the United States and worldwide particularly among women of 15-24 years. In many cases, it does not show any signs and symptoms in the initial stage, but it may lead to severe reproductive health issues if not treated. This article aims at educating the health care practitioners, learners, and the community on how to identify, treat, and prevent chlamydia.
Chlamydia: Symptoms, Detection, and Mechanism
It is sometimes difficult to diagnose chlamydia in its early stages since many people, particularly women, do not have any symptoms. However, when symptoms are present, they may include; discharge from the vagina, burning sensation when passing urine, discomfort in the vagina or pelvic pain. In the case described, the 21-year-old patient has a vaginal discomfort and discharge but no fever, nausea or severe pain which is typical for early stage chlamydia.
Chlamydia trachomatis is a bacterium that has an ability to reside and reproduce within host cells. It has two forms: the elementary body (EB) responsible for invasion of the host cells and the reticulate body (RB) which replicates in the host cells. After replication, RBs return to its original form of EBs and these are released in the body to infect other cells. This intracellular lifecycle helps the chlamydia to survive and avoid the host immune system. It does not come into contact with the host’s lysosomes since it lives in a membrane-bound vacuole.
The diagnosis is made using nucleic acid amplification tests (NAATs), for instance, cervical swab PCR test, which was positive in the given case. A urine test and a pregnancy test are often done together to eliminate other infection or diseases. There is no presence of blood, nitrites and leukocytes in the urine which indicates that the infection is localized and uncomplicated, especially in the early stages of chlamydia.
Chlamydia: Immunology, Therapy, and Counseling
When it is diagnosed, early treatment should be done to avoid worsening of the condition. In the immune response to chlamydia, the PRRs include TLRs that identify bacterial molecules. This leads to the production of pro-inflammatory cytokines such as interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α) and interferon-gamma (IFN-γ). Although this response helps in containing the infection, inflammation can cause harm to the tissues if the infection is not eradicated.
The recommended regimen for the treatment of uncomplicated chlamydia is doxycycline 100 mg twice a day for 7 days. Other options are azithromycin, but resistance rates are rising as well. Patients should be made to understand the need to take the whole course of antibiotics, avoid sexual activity during the period of the treatment, and inform other partners so that they can be tested and treated as well.
It may be advisable to repeat the test in pregnant women or if the symptoms do not disappear. It is recurrent, and therefore, it is recommended that a person is retested after every three months. They should also be advised on the need to take STI tests frequently especially when they engage in new or multiple sexual activities.
Risk factors for Chlamydia and safe practices and measures to enhance public health
Primary prevention involves identification of factors that may lead to the occurrence of the disease and imparting knowledge on safe sex practices. Young women are vulnerable since cervical ectopy, which exposes sensitive cells, is more likely to occur during adolescence. Other factors that increase the risk include; multiple partners, new partners, irregular use of condoms, and history of STI. In this case, the patient’s new sexual partner in the last two months may have put her at risk.
The measures that should be taken to promote healthy behavior among the sexually active individuals are the use of condoms, regular STI testing, and discussing the risks of STIs with sexual partners. The case of the patient taking contraceptives means that individuals on birth control think that they cannot contract STIs, which is why there is a need for sexual health education.
Chlamydia is a sexually transmitted disease, and the healthcare providers have the responsibility of conducting tests and recommending screening for sexually active people within the age of 25 years during their annual checkups or when they are attending family planning clinics. Schools, colleges, and community health programs should also offer STI information and resources and free or affordable testing services.
Therefore, chlamydia is not an incurable disease and when its symptoms are noticed early enough or preventive measures are put in place, it can be treated. If left untreated, some of the consequences are PID, infertility and ectopic pregnancy; these are some of the negative effects that can be prevented by adequate education and access to health care.
Conclusion
Chlamydia trachomatis remains a major public health problem because it is asymptomatic and can lead to severe complications. However, if there is keen observation, early identification, and effective measures taken to prevent the occurrence of the condition, then the effects can be minimized through a collaborative effort between the affected person and the healthcare providers. Prevention, education, and awareness are the ways through which the transmission of the disease and the subsequent risks to reproductive health can be stopped.
Related Assignment Question
Case Study Week 10
Patient is a 21-year-old female with no medical history. She reports vaginal discomfort and discharge for approximately 3 days. She is sexually active and has a new partner within the last 2 months. She denies fever, nausea or severe pain. The only medication the patient is taking is birth control.
DIAGNOSTIC:
Cervical swab PCR test is positive for chlamydia trachomatis
Urinalysis –
Color – yellow
Clarity – clear
pH – 7.0
Blood – negative
Nitrites – negative
Leukocytes – negative
POC Pregnancy – neg
Questions:
1. Describe the pathophysiologic process of chlamydia, including the two forms,
intracellular development, and immune evasion.
2. Explain the host’s response to the infection, including pathogen recognition
receptors and proinflammatory cytokines.
3. Explain the risk factors for STDs.
4. Explain the potential complications of Chlamydia.